Thursday, August 14, 2014 10:44:06 AM
The dilution will be extreme when they run out of cash for a 2nd time. People are saying "oh look at that balance sheet, etc" and YES it does look decent now. However, do you understand how expensive an FDA trial is? They will burn through a couple million per quarter several quarters in a row and BOOM - no more $$$. When they go back to the market for a 2nd round of fund raising you think terms will be favorable? Considering the fact these last institutions got killed in their agreements because of the artificial runup by the broker (forget their name).
The company WILL PROGRESS IN SALES and towards FDA PROGRESS and towards UPLISTING. However, can this outpace the dilution, competition of developing similiar products, etc.
I have been in this stock for 5 years now and many on this board have. In the last 5 years we have seen VERY LITTLE in terms of actual clinical data. The price shot to $0.45 5 years ago on ANTICIPATION of data. Now we still have none showing by reducing IL-6 (LOL your name!) it means patients survive greater during surgery or recover at a faster pace from surgery.
There are so many things to consider. People are only thinking about the positives and not the negatives.
At the end of the day you can hold your biased view and I can hold my biased view. However, who is right? Apparently I am since the stock market is agreeing with me and indicated by the price per share, volume and recent price action of the stock over the last 5 years.
I suggest if this runs up again you sell 50% of your position and cash it out. If the stock falls back down you buy the 50% back. I did this over the years and have made a return in the 100%'s and 100%'s of percentages. It is the only way to make a "DIVIDED" while you wait for the stock to really take off (if it ever does).
I am being sincere and honest with this post. You need to look at both sides of the argument when it comes to this stock. You cannot just read the propoganda PING posts and think the company is AMAZING!!! There are many things that are wrong. Why is this guy on team selling his shares week after week?
He has all the private information in the WORLD related to this stock. If he thought price was going to go up 5x do you think he would be selling lots of $20K when he could be selling lots of $100K in the near future? The guy makes good money. He has a savings account, etc. He is old. He doesnt need the money for a new house or car. Even if he did you dont think he would hold off knowing he could sell in 1-2 years at 5x the price???? LOL.. He is not an idiot guys. He is an educated man with private information and making educated decisions based on that information.
Recent CTSO News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2024 08:35:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 09:23:00 PM
- CytoSorbents Reports First Quarter 2024 Results • GlobeNewswire Inc. • 05/09/2024 08:17:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:14:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 09:00:30 PM
- CytoSorbents May 6, 2024 Virtual KOL and Analyst-Investor Day: STAR-T Pivotal Trial Topline Results & Real World Experience with Antithrombotic Drug Removal in Europe • GlobeNewswire Inc. • 05/02/2024 11:00:00 AM
- CytoSorbents to Report First Quarter 2024 Operating and Financial Results • GlobeNewswire Inc. • 04/26/2024 11:00:00 AM
- STAR-T Pivotal Trial Results to Be Featured as a Late-Breaking Presentation at the 2024 American Association for Thoracic Surgery Annual Meeting • GlobeNewswire Inc. • 04/17/2024 11:00:00 AM
- CytoSorbents to Report Fiscal 2023 Operating and Financial Results • GlobeNewswire Inc. • 03/06/2024 12:00:00 PM
- CytoSorbents to Present at the TD Cowen 44th Annual Health Care Conference • GlobeNewswire Inc. • 02/08/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/17/2024 10:20:45 PM
- Groundbreaking Randomized Controlled Trial Reports Excellent Clinical Outcomes Using CytoSorb® Intraoperatively in Heart Transplant Patients • GlobeNewswire Inc. • 01/17/2024 12:15:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 01/08/2024 08:00:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 09:49:02 PM
- CytoSorbents Provides Update on the STAR-T Trial and Reports Final Independent Data and Safety Monitoring Board Recommendation • GlobeNewswire Inc. • 12/28/2023 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:35:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:34:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:34:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:33:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:32:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:32:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:31:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:30:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/13/2023 02:15:22 PM
- CytoSorbents Announces Closing of $10.3 Million Registered Direct Offering • GlobeNewswire Inc. • 12/13/2023 02:15:00 PM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM